BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9684323)

  • 1. Screening of compounds for antimicrosporidial activity in vitro.
    Didier ES; Maddry JA; Kwong CD; Green LC; Snowden KF; Shadduck JA
    Folia Parasitol (Praha); 1998; 45(2):129-39. PubMed ID: 9684323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.
    Didier ES
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1541-6. PubMed ID: 9210681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.
    Didier PJ; Phillips JN; Kuebler DJ; Nasr M; Brindley PJ; Stovall ME; Bowers LC; Didier ES
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2146-55. PubMed ID: 16723577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a fluorescent probe to assess the activities of candidate agents against intracellular forms of Encephalitozoon microsporidia.
    Leitch GJ; Scanlon M; Shaw A; Visvesvara GS; Wallace S
    Antimicrob Agents Chemother; 1997 Feb; 41(2):337-44. PubMed ID: 9021189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cultivation of the human microsporidium Vittaforma corneae: development and effect of albendazole.
    Silveira H; Canning EU
    Folia Parasitol (Praha); 1995; 42(4):241-50. PubMed ID: 8774778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel in vitro method for drug development for fish; application to test efficacy of antimicrosporidian compounds.
    Saleh M; Kumar G; Abdel-Baki AA; Dkhil M; El-Matbouli M; Al-Quraishy S
    Vet Rec; 2014 Dec; 175(22):561. PubMed ID: 25200429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.
    Ridoux O; Drancourt M
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3301-3. PubMed ID: 9835533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsporidiosis: an emerging and opportunistic infection in humans and animals.
    Didier ES
    Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo.
    Didier ES; Bowers L; Stovall ME; Kuebler D; Mittleider D; Brindley PJ; Didier PJ
    Folia Parasitol (Praha); 2005 May; 52(1-2):173-81. PubMed ID: 16004377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.
    Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2729-32. PubMed ID: 9420047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro.
    Franssen FF; Lumeij JT; van Knapen F
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1265-8. PubMed ID: 7574513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of four antimicrobials against an Encephalitozoon sp. (Microsporidia) in a grasshopper host.
    Johny S; Whitman DW;
    Parasitol Int; 2008 Sep; 57(3):362-7. PubMed ID: 18495525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing intra-hemocelic injection of antimicrobials against Encephalitozoon sp. (Microsporidia) in an insect host.
    Johny S; Nimmo AS; Fisher MA; Inks ES; Kirkpatrick RM; Miller PA; Johnson AL; Lites KR; Whitehouse CC; Whitman DW
    Parasitol Res; 2009 Jan; 104(2):419-24. PubMed ID: 18850113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Nosema bombi and its treatment fumagillin on bumble bee (Bombus occidentalis) colonies.
    Whittington R; Winston ML
    J Invertebr Pathol; 2003 Sep; 84(1):54-8. PubMed ID: 13678713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNP-470 is an effective antimicrosporidial agent.
    Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
    J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro culture of various species of microsporidia causing keratitis: evaluation of three immortalized cell lines.
    Joseph J; Sharma S
    Indian J Med Microbiol; 2009; 27(1):35-9. PubMed ID: 19172057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insect system for testing antibiotics.
    Johny S; Lange CE; Solter LF; Merisko A; Whitman DW
    J Parasitol; 2007 Dec; 93(6):1505-11. PubMed ID: 18314700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin.
    Wilkins JH; Joshi N; Margolis TP; Cevallos V; Dawson CR
    Eye (Lond); 1994; 8 ( Pt 6)():703-4. PubMed ID: 7867837
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic targets for the treatment of microsporidiosis in humans.
    Han B; Weiss LM
    Expert Opin Ther Targets; 2018 Nov; 22(11):903-915. PubMed ID: 30336698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of Encephalitozoon intestinalis (Microspora) replication kinetics in a murine intestinal cell line.
    Wasson K; Barry PA
    J Eukaryot Microbiol; 2003; 50(3):169-74. PubMed ID: 12836873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.